[
    [
        {
            "time": "",
            "original_text": "重慶智飛生物去年業績增55%-75%，未來將重啟定增",
            "features": {
                "keywords": [
                    "智飛生物",
                    "業績增長",
                    "定增"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "醫療",
                    "生物技術"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "重慶智飛生物去年業績增55%-75%，未來將重啟定增",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "是否存在向殷盛昌輸送利益的情形？博雅生物收購羅益生物遭連環15問",
            "features": {
                "keywords": [
                    "博雅生物",
                    "羅益生物",
                    "利益輸送",
                    "收購質疑"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫療",
                    "生物技術"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "是否存在向殷盛昌輸送利益的情形？博雅生物收購羅益生物遭連環15問",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]